Proactive
Proactive is the leading digital news and media group, dominating the "Small-Mid Cap" companies investor sector across four continents. Proactive Investors Australia is a part of the largest global financial investor network with offices in Australia, Europe, Asia and North America.
See more information about Proactive
AgraFlora Organics International receives cannabis edibles processing license for its Winnipeg manufacturing facility
AgraFlora Organics International Inc (CSE:AGRA) (OTCPINK:AGFAF) (FRA:PU31) announced that on December 11, 2020, it received a newly-issued standard processing license from Health Canada for the company's 51,000-square-foot, fully-automated cannabis edibles manufacturing facility in Winnipeg, Manitoba.
The facility is part of the Edibles and Infusions Corporation (EIC) joint venture formed between AgraFlora and one of North America's leading confectionary manufacturing families.
"We are delighted to receive the Manufacturing License at our Edibles Facility within our outlined timeframe. Our strong evidence package submission is a testament to the hard-working team we have assembled. We are now able to commercialize our formulations and bring to market cannabis activated pectin and gelatin gummies, hard candy, and sugar-free variants," EIC co-founder and operational manager James Fletcher said in a statement.
The Winnipeg manufacturing facility, when fully operational, expects to produce more than 250,000 pieces of precisely-dosed edibles per eight-hour shift.
AgraFlora added that it will continue to focus on completing long-term production relationships through the culmination of the recently-announced Research and Development (R&D) trials through its Health Canada R&D license.
The company recently acquired High Performance Liquid Chromatography (HPLC) equipment for the manufacturing facility, which it says will allow it to rapidly develop and launch new edibles products that have already been formulated.
AgraFlora Organics International grows, distributes and markets premium cannabis and cannabis-infused products. Its strategy is two-pronged: supply the Canadian recreational market with high-potency flower and edible products, while serving the European medical cannabis market.
The company said it expects to roll out the first cannabis sales in mid 2Q 2021 from cultivation operations at the Propagation Services Canada (PSC) facility in Delta, British Columbia, which it anticipates will produce 10,000 plants yielding 50 grams per plant of saleable product in 2021.
Shares of AgraFlora Organics International gained 33% to $0.04 following the announcement.
Other Proactive news
- Humanigen showing positive results for cancer drug lenzilumab, also used to treat patients hospitalized with coronavirus
2020-12-08 - Delta 9 Cannabis debuts new decontamination pods to help fight coronavirus
2020-12-08 - XPhyto touts rapid 25-minute RT-PCR lab test for coronavirus detection
2020-10-28 - One World Lithium to start proof of concept program testing potential lithium separation technology
2020-10-27 - Revive Therapeutics commits to 10 sites for Phase 3 coronavirus trial of bucillamine
2020-10-26
